<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Pre-diagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-12-07">2018 December 07.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">J</forename><surname>Hughes #</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiology &amp; Centre for Systems Medicine</orgName>
								<orgName type="institution">Royal College of Surgeons in Ireland</orgName>
								<address>
									<addrLine>31A York Street, Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Talita</forename><surname>Duarte-Salles #</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Nutrition and Metabolism</orgName>
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Institut Universitari d&apos;Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol)</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sandra</forename><surname>Hybsier</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antonia</forename><surname>Trichopoulou</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Unit of Nutritional Epidemiology and Nutrition in Public Health</orgName>
								<orgName type="department" key="dep2">Dept. of Hygiene, Epidemiology and Medical Statistics</orgName>
								<orgName type="laboratory">WHO Collaborating Center for Nutrition and Health</orgName>
								<orgName type="institution">University of Athens Medical School</orgName>
								<address>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Magdalena</forename><surname>Stepien</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Nutrition and Metabolism</orgName>
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Krasimira</forename><surname>Aleksandrova</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">German Institute of Human Nutrition</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kim</forename><surname>Overvad</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Section for Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Public Health</orgName>
								<orgName type="institution">Aarhus University</orgName>
								<address>
									<settlement>Aarhus</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>Tjønneland</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Danish Cancer Society Research Center</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><surname>Olsen</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Danish Cancer Society Research Center</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aurélie</forename><surname>Affret</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Inserm</orgName>
								<orgName type="institution" key="instit2">CESP Centre for Research in Epidemiology and Population Health</orgName>
								<address>
									<addrLine>Lifestyle, genes and health: integrative trans-generational epidemiology</addrLine>
									<postCode>U1018, F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">UMRS 1018</orgName>
								<orgName type="institution">Univ Paris Sud</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guy</forename><surname>Fagherazzi</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Inserm</orgName>
								<orgName type="institution" key="instit2">CESP Centre for Research in Epidemiology and Population Health</orgName>
								<address>
									<addrLine>Lifestyle, genes and health: integrative trans-generational epidemiology</addrLine>
									<postCode>U1018, F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">UMRS 1018</orgName>
								<orgName type="institution">Univ Paris Sud</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marie-Christine</forename><surname>Boutron-Ruault</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Inserm</orgName>
								<orgName type="institution" key="instit2">CESP Centre for Research in Epidemiology and Population Health</orgName>
								<address>
									<addrLine>Lifestyle, genes and health: integrative trans-generational epidemiology</addrLine>
									<postCode>U1018, F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">UMRS 1018</orgName>
								<orgName type="institution">Univ Paris Sud</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Katzke</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Division of Cancer Epidemiology</orgName>
								<orgName type="department" key="dep2">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rudolf</forename><surname>Kaaks</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Division of Cancer Epidemiology</orgName>
								<orgName type="department" key="dep2">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heiner</forename><surname>Boeing</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">German Institute of Human Nutrition</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christina</forename><surname>Bamia</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Unit of Nutritional Epidemiology and Nutrition in Public Health</orgName>
								<orgName type="department" key="dep2">Dept. of Hygiene, Epidemiology and Medical Statistics</orgName>
								<orgName type="laboratory">WHO Collaborating Center for Nutrition and Health</orgName>
								<orgName type="institution">University of Athens Medical School</orgName>
								<address>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pagona</forename><surname>Lagiou</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Unit of Nutritional Epidemiology and Nutrition in Public Health</orgName>
								<orgName type="department" key="dep2">Dept. of Hygiene, Epidemiology and Medical Statistics</orgName>
								<orgName type="laboratory">WHO Collaborating Center for Nutrition and Health</orgName>
								<orgName type="institution">University of Athens Medical School</orgName>
								<address>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eleni</forename><surname>Peppa</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Domenico</forename><surname>Palli</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Molecular and Nutritional Epidemiology Unit</orgName>
								<orgName type="institution">Cancer Research and Prevention Institute -ISPO</orgName>
								<address>
									<settlement>Florence</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vittorio</forename><surname>Krogh</surname></persName>
							<affiliation key="aff15">
								<orgName type="laboratory">Epidemiology and Prevention Unit</orgName>
								<orgName type="institution">Fondazione IRCCS Istituto Nazionale dei Tumori</orgName>
								<address>
									<addrLine>Via Venezian, 1</addrLine>
									<postCode>20133</postCode>
									<settlement>Milano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Salvatore</forename><surname>Panico</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Dipartimento di Medicina Clinica e</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rosario</forename><surname>Tumino</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution" key="instit1">Cancer Registry and Histopathology Unit, &quot;Civic -M.P.Arezzo&quot; Hospital</orgName>
								<orgName type="institution" key="instit2">ASP Ragusa</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cristina</forename><surname>Lasheras</surname></persName>
							<affiliation key="aff32">
								<orgName type="institution">Oviedo University</orgName>
								<address>
									<settlement>Asturias</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antonio</forename><surname>Agudo</surname></persName>
							<affiliation key="aff33">
								<orgName type="laboratory">Unit of Nutrition, Environment and Cancer.Cancer Epidemiology Research Program</orgName>
								<orgName type="institution">Catalan Institute of Oncology-IDIBELL. L&apos;Hospitalet de Llobregat</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria- José</forename><surname>Sánchez</surname></persName>
							<affiliation key="aff34">
								<orgName type="institution">Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/ Universidad de Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff35">
								<orgName type="institution">CIBER de Epidemiología y Salud Pública (CIBERESP)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Navarro</surname></persName>
							<affiliation key="aff35">
								<orgName type="institution">CIBER de Epidemiología y Salud Pública (CIBERESP)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff36">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">Murcia Regional Health Council</orgName>
								<orgName type="institution" key="instit2">IMIB-Arrixaca</orgName>
								<address>
									<settlement>Murcia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department">Department of Health and Social Sciences</orgName>
								<orgName type="institution">Universidad de Murcia</orgName>
								<address>
									<settlement>Murcia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eva</forename><surname>Ardanaz</surname></persName>
							<affiliation key="aff35">
								<orgName type="institution">CIBER de Epidemiología y Salud Pública (CIBERESP)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff38">
								<orgName type="institution">Navarra Public Health Institute</orgName>
								<address>
									<settlement>Pamplona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff39">
								<orgName type="institution" key="instit1">IdiSNA</orgName>
								<orgName type="institution" key="instit2">Navarra Institute for Health Research</orgName>
								<address>
									<settlement>Pamplona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miren</forename><surname>Dorronsoro</surname></persName>
							<affiliation key="aff40">
								<orgName type="laboratory">Public Health Direction and biodonostia-Ciberesp</orgName>
								<orgName type="institution">Basque regional health department</orgName>
								<address>
									<settlement>San Sebastian</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Oskar</forename><surname>Hemmingsson</surname></persName>
							<affiliation key="aff41">
								<orgName type="department">Department of Surgical and Perioperative Sciences</orgName>
								<orgName type="institution">Umeå University</orgName>
								<address>
									<settlement>Umeå</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nick</forename><surname>Wareham</surname></persName>
							<affiliation key="aff42">
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kay-Tee</forename><surname>Khaw</surname></persName>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Clinical Gerontology</orgName>
								<orgName type="department" key="dep2">School of Clinical Medicine</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kathryn</forename><surname>Bradbury</surname></persName>
							<affiliation key="aff44">
								<orgName type="department">Department of Population Health</orgName>
								<orgName type="laboratory">Cancer Epidemiology Unit</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Nuffield</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Amanda</forename><forename type="middle">J</forename><surname>Cross</surname></persName>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Gunter</surname></persName>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elio</forename><surname>Riboli</surname></persName>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isabelle</forename><surname>Romieu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Nutrition and Metabolism</orgName>
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lutz</forename><surname>Schomburg</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mazda</forename><surname>Jenab</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Nutrition and Metabolism</orgName>
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">David</forename><forename type="middle">J</forename><surname>Hughes</surname></persName>
							<email>davidhughes@rcsi.ie.</email>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department">Department of Physiology &amp; Centre for Systems Medicine</orgName>
								<orgName type="institution">Royal College of Surgeons in Ireland</orgName>
								<address>
									<addrLine>31A York Street, Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="institution">Chirurgia Federico II</orgName>
								<address>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department">Center for Cancer Prevention (CPO)</orgName>
								<orgName type="laboratory">Unit of Cancer Epidemiology</orgName>
								<orgName type="institution">Scienza Hospital-University of Turin</orgName>
								<address>
									<addrLine>Citta&apos; della Salute e della, Via Santena 7</addrLine>
									<postCode>10126</postCode>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department">Department for Determinants of Chronic Diseases (DCD)</orgName>
								<orgName type="institution">National Institute for Public Health and the Environment (RIVM)</orgName>
								<address>
									<settlement>Bilthoven</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="department">Department of Gastroenterology and Hepatology</orgName>
								<orgName type="institution">University Medical Centre</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department" key="dep1">Department of Social &amp; Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Malaya</orgName>
								<address>
									<settlement>Kuala Lumpur</settlement>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">Julius Center for Health Sciences and Primary Care</orgName>
								<orgName type="department" key="dep3">Department of Epidemiology and Biostatics</orgName>
								<orgName type="department" key="dep4">School of Public Health</orgName>
								<orgName type="institution">MRC-PHE Centre for Environment and Health</orgName>
								<address>
									<addrLine>University Medical Center Utrecht 25</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">Imperial College</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="institution">The Norwegian Scientific Committee for Food Safety (VKM)</orgName>
								<address>
									<settlement>Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department" key="dep1">Department of Community Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution" key="instit1">University of Tromsø</orgName>
								<orgName type="institution" key="instit2">The Arctic University of Norway</orgName>
								<address>
									<settlement>Tromsø</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">Department of Research</orgName>
								<orgName type="institution">Cancer Registry of Norway</orgName>
								<address>
									<settlement>Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="department">Department of Medical Epidemiology and Biostatistics</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="laboratory">Genetic Epidemiology Group</orgName>
								<orgName type="institution">Folkhälsan Research Center</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Pre-diagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-12-07">2018 December 07.</date>
						</imprint>
					</monogr>
					<idno type="MD5">F633CFC6232D7FC5C5DEE14A4F64B05F</idno>
					<idno type="DOI">10.3945/ajcn.116.131672</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>hepatocellular carcinoma</term>
					<term>selenium</term>
					<term>selenoprotein P</term>
					<term>prospective cohort c</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background-Selenium (Se) status is suboptimal in many Europeans, and may be a risk factor for development of various cancers including those of the liver and biliary tract.</s></p><p><s>Objective-We wished to examine if Se status in advance of cancer onset is associated with hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.</s></p><p><s>Design-We assessed pre-diagnostic Se status by measuring serum levels of Se and Selenoprotein P (SePP; the major circulating Se transfer protein) and examined the association with hepatocellular carcinoma (HCC; N=121), gallbladder and biliary tract cancers (GBTC, N=100), and intrahepatic bile duct (IHBC; N=40) cancer risk in a nested case-control design within the EPIC study.</s><s>Se was measured by total reflection X-ray fluorescence and SePP by a colorimetric sandwich ELISA.</s><s>Multivariable odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression.</s></p><p><s>Results-HCC and GBTC cases, but not IHBC, had significantly lower circulating Se and SePP levels than their matched controls.</s><s>Higher circulating Se was associated with a significantly lower HCC risk (OR=0.41,</s><s>95%CI: 0.23, 0.72 per 20 μg/L increase) but not with risk of GBTC or IHBC.</s><s>Similarly, higher SePP concentration was associated with lowered HCC risk only in both the categorical and continuous analyses (HCC: P trend =&lt;0.0001;</s><s>OR=0.37, 95%CI: 0.21, 0.63 per 1.5 mg/L increase).</s></p><p><s>Conclusions-These findings from a large prospective cohort provide evidence that suboptimal Se status in Europeans may be associated with an appreciably increased risk of HCC development.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Worldwide, primary liver cancers (PLC=hepatocellular carcinomas [HCC] and intrahepatic bile duct cancer <ref type="bibr">[IHBC]</ref>) are the sixth most commonly diagnosed cancer group <ref type="bibr" target="#b0">(1)</ref>, and have the second highest cancer mortality rate(2).</s><s>Geographic variation in PLC incidence rates reflects the prevalence of two established risk factors -viral hepatitis B/C (HBV/HCV) and aflatoxin exposure <ref type="bibr" target="#b2">(3)</ref>.</s><s>However, current data show that PLC rates are rapidly increasing in traditionally lower-risk industrialized countries <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b4">5)</ref>, likely due to Western lifestyle and dietary habits.</s><s>The group of biliary tract cancers (GBTC; tumours of the gallbladder and extra-hepatic bile ducts) are anatomically related to PLC and both these cancer types are difficult to detect early, have poor prognoses and have limited understood aetiology <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>.</s><s>Thus, greater scientific understanding of the role of diet and lifestyle factors in the aetiology of hepatobiliary cancers is important.</s></p><p><s>A growing body of experimental and observational evidence suggests that suboptimal intakes of the micronutrient selenium (Se) contribute to the development of several cancers <ref type="bibr" target="#b7">(8)</ref>.</s><s>Se is incorporated as the amino acid selenocysteine in selenoproteins which are thought to help prevent carcinogenesis largely due to the role of several of these proteins in cell protection from oxidative stress, redox control and the inflammatory response <ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b9">(10)</ref><ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref>.</s><s>Data from intervention trials and epidemiological studies suggest implications for Se intake in cancer risk are probably more apparent in populations with low Se availability, such as many across Europe <ref type="bibr" target="#b12">(13)</ref><ref type="bibr" target="#b13">(14)</ref><ref type="bibr" target="#b14">(15)</ref>.</s></p><p><s>Absorbed Se is primarily retained by the liver and re-circulated as a constituent of Selenoprotein P (SePP) <ref type="bibr" target="#b15">(16)</ref>.</s><s>Se and SePP are the two major biomarkers of blood Se status, while SePP also affects the expression of anti-oxidative selenoproteins <ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref>.</s><s>Se has been shown to play vital roles in multiple metabolic processes in the liver <ref type="bibr" target="#b19">(20)</ref>.</s><s>Evidence from primary human hepatocytes and animal models implicate Se in liver cancer development <ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b23">(24)</ref>, while decreasing Se concentrations in HCC tumor tissues were associated with progressive cancer grade <ref type="bibr" target="#b24">(25)</ref>.</s><s>A Chinese prospective study also showed an inverse association between toenail Se status and risk of HCC mortality <ref type="bibr" target="#b25">(26)</ref>.</s><s>Se deficiency has been observed in patients with alcoholic liver cirrhosis and primary biliary cirrhosis <ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref><ref type="bibr" target="#b28">(29)</ref>.</s><s>Interestingly, low Se intake is thought to increase vulnerability to viral infections, which may be particularly important due to the marked link between hepatitis virus infection and liver cancer development <ref type="bibr" target="#b9">(10)</ref><ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b29">30)</ref>.</s><s>In support of this, findings from a cohort of chronic HBV and/or HCV carriers in Taiwan show an inverse association between HCC development risk and plasma Se levels <ref type="bibr" target="#b30">(31)</ref>.</s><s>However, to date there is no major epidemiologic evidence exploring the association of Se status with hepatobiliary cancers risk in European populations.</s><s>In the present study, we hypothesized that a low Se status is associated with a higher risk of hepatobiliary cancer development.</s><s>Thus, our aim was to assess the association between pre-diagnostic circulating levels of Se and SePP with HCC, GBTC, and IHBC risk in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design and population</head><p><s>EPIC is a large prospective cohort study designed to investigate the association between diet, lifestyle and environmental factors and the incidence of cancers and other chronic diseases.</s><s>Detailed information on the study design, rationale and methods of the EPIC study, including assessment of diet and lifestyle factors, has been described previously <ref type="bibr" target="#b31">(32,</ref><ref type="bibr" target="#b32">33)</ref>.</s><s>Briefly, between 1992 and 2000 more than 520,000 men and women mostly aged 25-70 years were recruited in 23 centres throughout 10 European countries (Denmark/France/ Germany/Greece/Italy/the Netherlands/Norway/Spain/Sweden/the United Kingdom).</s><s>At recruitment, standardised dietary, lifestyle and socio-demographic questionnaires including information on physical activity, education, smoking and medical history; anthropometric data, and blood samples were collected from participants.</s><s>Blood samples are stored at the International Agency for Research on Cancer (IARC, Lyon, France) in -196°C liquid nitrogen for all countries except Denmark (-150°C, nitrogen vapour) and Sweden (-80°C, freezers).</s><s>All cohort members provided written informed consent.</s><s>Ethical approval for this study was obtained from the IARC ethical review board (Lyon, France) and local participating centres.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Follow-up for Cancer Incidence and Mortality</head><p><s>Vital status follow-up (98.5% complete) was collected by record linkage with regional and/or national mortality registries in all countries except Germany and Greece, where follow-up is based on active follow-up through study subjects or their next-of-kin.</s><s>Cancer incidence was determined through record linkage with population-based regional cancer registries (Denmark/Italy/the Netherlands/Norway/Spain/Sweden/the United Kingdom) or via a combination of methods, including the use of health insurance records, contacts with cancer and pathology registries, and active follow-up through study subjects and their nextof-kin (France/Germany/Greece).</s><s>For this study, the latest date of complete information for cancer incidence and vital status ranged from December 2002 to December 2006 among different centres.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Case Ascertainment</head><p><s>First incident HCC and IHBC were defined as C22.0 and C22.1, respectively, as per the 10 th Revision of the International Statistical Classification of Diseases, Injury and Causes of Death (ICD-10) and the 2 nd edition of the International Classification of Diseases for Oncology (ICD-O-2).</s><s>Gallbladder and biliary tract cancers (GBTC) included tumours in the gallbladder (C23.9),</s><s>extrahepatic bile ducts (C24.0),</s><s>Ampulla of Vater (C24.1), and biliary tract (C24.8 and C24.9) with morphology code ICD-O-2 "8162/3".</s><s>Cholangiocarcinoma was defined as tumors in the intra/extrahepatic bile ducts (morphology code ICD-O-2 "8160/3").</s><s>For each identified case, the histology and the methods used to diagnose the cancer were reviewed to exclude metastatic cases or other types of liver cancers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nested Case-Control Study Design</head><p><s>The design of the nested case-control study has been previously described in detail <ref type="bibr" target="#b33">(34)</ref>.</s><s>The sample size for the present analysis (261 cases, 261 controls) was based on cases identified between recruitment into the cohort until 2006 and availability of blood samples for Se status analysis (see the flow chart in the Supplemental Figure <ref type="figure">1</ref>).</s><s>For SePP, all of the available 121 HCC, 100 GBTC (gallbladder = 44, Ampulla of Vater = 19, and biliary tract = 37), and 40 IHBC cases were analysed (261 case-control pairs), including 35 cholangiocarcinoma cases (intrahepatic = 29 and extrahepatic = 6) within the GBTC and IHBC groups.</s><s>For Se, fewer cases were available due to insufficient volume of blood sample or failed laboratory assay (106 HCC, 96 GBTC, and 36 IHBC cases included and 27 cases excluded) so that 238 case-control pairs were successfully analysed.</s><s>For each case, one control was selected by incidence density sampling from all cohort members alive and free of cancer (except non-melanoma skin cancer), and matched by age at blood collection (±1 year), sex, study center, time of day (±3 hours) and fasting status (&lt;3,3-6,and &gt;6 hours) at blood collection.</s><s>Women were additionally matched by menopausal status (pre-, peri-, and postmenopausal), and hormone replacement therapy use at time of blood collection (yes/no).</s></p><p><s>Existing data for HBV and HCV seropositivity, as well as α-fetoprotein (AFP), c-reactive protein [CRP] and markers of liver injury (alanine aminotransferase [ALT], aspartate aminotransferase [AST], gamma-glutamyltransferase [GGT], liver-specific alkaline phosphatase [AP], albumin, total bilirubin) were available and measured as previously detailed elsewhere <ref type="bibr" target="#b34">(35)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum Se and SePP measurements</head><p><s>The case-control status was blinded.</s><s>Concentrations of total Se were measured by X-ray fluorescence as described previously <ref type="bibr" target="#b35">(36)</ref>.</s><s>Briefly, 4 µL of serum sample was analysed using a bench-top total reflection X-ray fluorescence (TXRF) spectrometer (PicofoxTM S2, Bruker Nano GmbH, Berlin, Germany).</s><s>For quantification of Se a certified reference gallium solution (1,000 mg/L, Sigma, Taufkirchen, Germany) with a defined concentration was equally added to each sample.</s><s>An internal serum standard was applied to each measurement.</s><s>The inter-assay coefficient of variation (CV) of this standard was a 10.0% relative standard deviation within 48 analysis tests.</s><s>A colorimetric enzyme-linked immunoassay (SelenotestTM, ICI GmbH, Berlin, Germany) was used to measure SePP levels from 5 µL of each serum sample in a 1:21 dilution according to the manufacturer's instructions.</s><s>The CVs were determined with three controls covering the upper, middle and lower part of the assay's working range (13.5-484.8</s><s>µg/L).</s><s>These controls were included in 16 assay procedures, and yielded a CV of 4.1%, 6.7% and 11.4% for controls 1 (SePP: 18.2 µg/L), 2 (SePP: 79.0 µg/L) and 3 (SePP: 292.9 µg/L), respectively.</s><s>The evaluation was performed with GraphPad Prism 6.01 (La Jolla, CA) using a four parameter logistic function.</s><s>The samples were measured in duplicate and the mean concentration values, standard deviation (SD) and coefficient of variation were calculated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p><s>Generalized linear models (GLM) (values were natural logarithm transformed to approximate a normal distribution) were used to examine geometric mean differences in Se and SePP concentrations among the controls by baseline characteristics, with adjustment for country and sex.</s><s>P-values for tests of trend (for ordinal variables) or of heterogeneity were reported.</s></p><p><s>Conditional logistic regression models were used to calculate the odds ratio (OR) with 95% confidence interval (CI) and tests for trend for associations between circulating Se and SePP in relation to risk of HCC, GBTC, and IHBC, as well as specific sub-sites of the gallbladder, and cholangiocarcinoma (intra-and extra-hepatic).</s><s>Se and SePP concentrations were included in models as continuous (per 20 µg/L and 1.50 mg/L, respectively; approximately one SD) and as categorical variables, with tertile cut-points based on the distribution in all control subjects.</s><s>Models were run separately for each cancer site using the same categorical cut-points for all tests.</s><s>Tests for dose-response by linear trend were performed by assigning the median values of each tertile of Se and SePP.</s></p><p><s>For all analyses, both crude and multivariable models were run.</s><s>Crude models included matching factors; multivariable models were additionally adjusted for a priori selected confounders including baseline alcohol intake at recruitment (g/d), pattern of lifetime alcohol intake (never drinkers, former drinkers, drinkers only at recruitment, always drinkers, unknown), body mass index (BMI; kg/m2), smoking status (never, former, current, and not specified), level of education (none/primary school, technical school, secondary school, university degree or higher), physical activity (combination of physical activity, cycling and sport activities in metabolic equivalents [METs]), waist circumference (cm), total energy intake (kcal/day), and self-reported diabetes.</s><s>Other factors (height, weight, waist-to-hip ratio, and dietary intake of energy, fibre, tea, coffee, red and processed meats, fish and shellfish, fruits and vegetables) were tested as potential confounders, but were excluded from final models for parsimony, as they did not affect our estimates (change-inestimate &lt;10%).</s></p><p><s>Interactions for potential biologically plausible effect modifying variables (age at diagnosis, BMI, self-reported diabetes) was tested by including interaction terms formed by the product of modifying variable categories and the value of categories of exposure of interest.</s><s>In order to explore the main proposed underlying mechanism of Se action (i.e.</s><s>antioxidant defence), we also tested interactions with circulating CRP (a marker of chronic inflammation, likely to be heightened under oxidative stress) and smoking (since smokers are under oxidative stress and have higher antioxidant defence requirements).</s><s>Since subjects with alcoholic liver cirrhosis have been observed to have lower Se status <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b27">28)</ref>, we explored interactions with alcohol intake.</s><s>The statistical significance of interactions was assessed using likelihood ratio tests based on the models with and without the interaction terms.</s><s>In sensitivity analyses, we excluded subjects with (i) self-reported type 2 diabetes at baseline (yes/no), because of the potential for modifications in diet after diagnosis of this disease, (ii) hepatitis infection, since it is an established risk factor for liver cancers, and (iii) subjects with follow-up of &lt;2 or &lt;4 years after blood collection to exclude possible reverse causation.</s><s>Additional analyses were performed including adjustment for an ad hoc liver function score (range from 0 to 6; categorized as 0=no liver injury, 1-2=possible minor injury, ≥3=possible injury), which summarizes the number of abnormal values for six liver function tests (ALT&gt;55 U/L, AST&gt;34 U/L, GGT men&gt;64 U/L, GGT women&gt;36 U/L, AP&gt;150 U/L, albumin&lt;35 g/L, total bilirubin&gt;20.5</s><s>μmol/L; cut-points were provided by the laboratory and were based on assay specifications).</s></p><p><s>All statistical tests were two-sided, and p-values&lt;0.05 were considered statistically significant.</s><s>Analyses were performed using Stata version 11 (StataCorp, College Station, Texas) statistical package.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline Characteristics of Participants</head><p><s>The baseline characteristics of all study subjects are presented in Table <ref type="table">1</ref>.</s><s>HCC, GBTC, and IHBC cases were diagnosed, on average, 6.0, 5.5, and 5.9 years after blood collection, respectively.</s><s>HCC cases were more likely to be current smokers, to be former alcohol drinkers, to have higher waist circumference, to have chronic HBV and/or HCV infection and liver enzyme abnormalities, and to have lower intakes of fruits and vegetables compared to their matched controls.</s><s>For GBTC and IHBC, none of the variables in Table <ref type="table">1</ref> were significantly different between cases and controls.</s><s>Serum concentrations of SePP and Se showed a strong, significant correlation among cases and controls (r =0.62; P=&lt;0.001).</s><s>Geometric means of serum Se were significantly lower in HCC and GBTC cases vs. their respective matched controls (71.3 vs. 85.2 µg/L; P=&lt;0.001, and 82.1 vs. 85.9 µg/L; P=0.041, respectively), while no significant differences were observed for IHBC.</s><s>Concentrations of SePP were lower in HCC cases vs. controls (geometric means were 4.3 vs. 5.4 mg/L; P=&lt;0.001, respectively), and did not differ significantly among GBTC or IHBC cases and controls.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HCC</head><p><s>The associations between serum Se and SePP concentrations with HCC risk are shown in Table <ref type="table">2</ref>.</s><s>A higher Se concentration was statistically significantly associated with lower HCC risk (multivariable OR T3 vs.</s><s>T1 =0.18, 95%CI: 0.05, 0.66, P trend =0.016; OR=0.41, 95%CI: 0.23, 0.72 per 20 μg/L increase in Se concentration).</s><s>Similarly, SePP levels were highly significantly associated with lower HCC risk (multivariable OR T3 vs.</s><s>T1 =0.09, 95%CI: 0.03, 0.32, P trend =&lt;0.0001;</s><s>OR=0.37, 95%CI: 0.21, 0.63 per 1.5 mg/L increase in SePP concentration).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GBTC</head><p><s>The associations between serum Se and SePP concentrations with GBTC risk are also shown in Table <ref type="table">2</ref>. Higher serum Se levels were not associated with a statistically significant lower risk of GBTC (multivariable OR T3 vs.</s><s>T1 =0.37, 95%CI: 0.13, 1.03, P trend =0.055; OR=0.74, 95%CI: 0.47, 1.18 per 20 μg/L increase in Se concentration), although the dose response estimate was close to significance (P trend =0.055) and was significant when analyzed by matching factors only (P trend =0.022).</s><s>Higher SePP levels were significantly associated with lower GBTC risk (multivariable OR T3 vs.</s><s>T1 =0.27, 95%CI: 0.09, 0.78, P trend =0.016).</s></p><p><s>However, the association between SePP levels and GBTC risk was not significant when SePP was analyzed as a continuous variable (multivariable OR=0.79, 95%CI: 0.51, 1.21 per 1.5 mg/L increase in SePP concentration).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hepatobiliary cancer subtypes</head><p><s>The associations between serum Se and SePP concentrations with risk of other hepatobiliary cancer subtypes (IHBC, gallbladder, and cholangiocarcinoma cancers) are shown in Table <ref type="table">3</ref> (note that gallbladder cancers were also included in the GBTC category and cholangiocarcinoma cancers in the GBTC and IHBC groups).</s><s>Due to the modest numbers of case-control pairs for these sites, we only analyzed the Se status markers for the continuous model.</s><s>Although all point estimates indicated a lowered risk for all these cancers with increases in Se and SePP concentrations, none were statistically significant after multivariable adjustment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sensitivity analyses and Effect Modifications</head><p><s>The results did not change substantially after exclusion of participants that self-reported type 2 diabetes at baseline or cases diagnosed during the first 2 or 4 years of follow-up, as well as after additional adjustment for liver function score (results not shown).</s><s>Among hepatitis free HCC cases (n cases =52), the association with Se was not statistically significant (multivariable OR for 20 µg/L=0.52,</s><s>95%CI: 0.26, 1.05), while the association with SePP remained statistically significant after exclusion of HBV/HCV positive cases (multivariable OR for 1.5 mg/L= 0.51, 95%CI: 0.26, 0.99).</s><s>However, we did not observe statistically significant effect modification by hepatitis infection status (P for interaction for Se and SePP were 0.425 and 0.854, respectively).</s><s>We observed a significant interaction between BMI and SePP concentrations on HCC risk (P for interaction in crude and multivariable models were 0.036 and 0.006, respectively).</s><s>The association between Se and SePP and HCC risk was stronger among overweight and obese than in normal weight participants.</s><s>We did not observe any statistically significant effect modifications for other factors such as smoking, CRP, alcohol intake or self-reported diabetes; also, no interactions were observed for other cancer subtypes (all P for interaction&gt;0.05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>This study presents the largest prospective examination of the association of serum Se status biomarkers (serum Se levels and SePP protein concentrations) with risk of HCC and GBTC in European populations.</s><s>Our findings indicate that higher levels of Se were significantly associated with a lower HCC risk but were not associated with GBTC risk.</s><s>Higher concentrations of SePP, a functional biomarker of Se status, were significantly associated with a lower risk of HCC and GBTC, although the latter association was only seen for the categorical analysis.</s><s>Analyses of distinct hepatobiliary cancer subtypes (IHBC, gallbladder, and cholangiocarcinoma) showed no significant associations with Se status levels, although we had limited power for these analyses.</s><s>Overall, the results suggest that in areas of marginally low Se status, such as the populations examined here from Western Europe <ref type="bibr" target="#b18">(19)</ref>, Se intake and/or status may be important factors in the development of HCC and GBTC.</s></p><p><s>Optimal Se intake should ensure a circulating Se level of at least 124μg/L to fully express SePP and Glutathione Peroxidase 3 (GPX3) selenoproteins <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38)</ref>.</s><s>In this study, the correlation between Se and SePP levels was relatively high (r=0.62;</s><s>P=&lt;0.001), reflecting that most subjects had suboptimal Se levels to fully saturate SePP (and GPX3), and very similar to our previous analysis of the same Se status markers in a separate study on colorectal cancer, also nested within EPIC <ref type="bibr" target="#b14">(15)</ref>.</s><s>This provides further evidence of the marginally low Se status in many Western European populations <ref type="bibr" target="#b18">(19)</ref>.</s><s>Attenuated expression of SePP and dysregulation of the expression of other selenoproteins resulting from suboptimal Se availability affects responses to important carcinogenic processes like oxidative stress <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b11">12)</ref> and this may underline the association of these Se status markers with liver cancer.</s></p><p><s>For both HCC and GBTC, the point estimates comparing the highest and lowest tertiles of circulating Se and SePP concentrations show strong inverse associations (as does the continuous estimate for HCC).</s><s>Although a preventative effect of Se against these cancers is in line with our hypothesis, the surprising strength of the observed association requires further confirmation.</s><s>Nevertheless, there are several lines of evidence to support a strong preventative effect of higher Se status levels against hepatobiliary cancers.</s><s>Mouse and rat models in particular have indicated a central role of the liver for Se metabolism <ref type="bibr" target="#b38">(39)</ref><ref type="bibr" target="#b39">(40)</ref><ref type="bibr" target="#b40">(41)</ref><ref type="bibr" target="#b41">(42)</ref><ref type="bibr" target="#b42">(43)</ref>. Data from SePP knockout mice suggest that healthy hepatocytes are the major cell type to contribute to circulating SePP levels <ref type="bibr" target="#b41">(42)</ref> and these cells are sensitive to oxidative and inflammatory stress <ref type="bibr" target="#b42">(43)</ref> and to hypoxia <ref type="bibr" target="#b43">(44)</ref>.</s><s>Together, these studies indicate that even a minor dysfunction of hepatocytes may reduce serum Se and SePP concentrations (through lower circulating SePP levels).</s><s>This suggests a potential mechanism of liver carcinogenesis whereby the dysregulation of SePP expression and secretion due to impaired Se organification (i.e., weakened conversion of dietary Se into selenoproteins such as SePP by sub-functional or de-differentiated hepatocytes) contributes to oxidative stress damage in hepatocytes.</s><s>In this scenario, SePP may be an early and sensitive indicator of hepatocyterelated liver health.</s><s>This may also explain why we observe weaker associations for GBTC compared to HCC and no signification associations for the other liver-related cancer sites that we investigated (IHBC, gallbladder, and cholangiocarcinoma cancers).</s></p><p><s>However, it remains possible that the strong estimates provided by this study may reflect, at least in part, that these Se markers are acting as biomarkers of liver disease, as seen for example in cirrhosis studies <ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref><ref type="bibr" target="#b28">(29)</ref>, and that this inadequate liver functioning may lead to cancer.</s><s>In this regard, it is notable that in a prospective study of men with chronic hepatitis infection a reduction in HCC risk was associated with higher plasma Se levels <ref type="bibr" target="#b30">(31)</ref>.</s><s>Our stratified analyses provide support for these Se measures as biomarkers of both general liver damage and liver cancer risk.</s><s>After excluding hepatitis positive cases, the association of HCC remained statistically significant with SePP but not Se.</s><s>Among groups with no marked liver damage, the association of HCC with Se or SePP was not significant, while for those with clear liver damage scores the association of decreased HCC risk was significant for higher SePP levels only.</s><s>However, we did not observe statistically significant effect modifications by either hepatitis infection status or liver damage scores (results not shown), which may be due to low power for these analyses.</s></p><p><s>Chemical forms of dietary Se such as selenomethionine, the major source of Se in the human diet, and Se selenite may differentially contribute to the amount of biologically usable Se for hepatocyte metabolism <ref type="bibr" target="#b44">(45)</ref>.</s><s>Such factors, along with baseline Se status levels, may partly explain varying successes of intervention trials of Se supplements to prevent cancer <ref type="bibr" target="#b13">(14,</ref><ref type="bibr" target="#b14">15)</ref>.</s><s>A national program of adding Se to fertilizers in Finland has indicated that Se status can be safely increased on a population-wide basis in low Se areas <ref type="bibr" target="#b45">(46)</ref>.</s><s>While a recent analysis on incidence rates of major cancers (though not including liver cancer) hasn't shown an obvious impact of this program, the lack of an adequate non-supplemented control group is a major problem in assessing these data <ref type="bibr" target="#b45">(46)</ref>.</s><s>Interestingly, intervention trials in China using selenized table salt or selenized yeast showed significant reductions in PLC incidence in the supplemented groups <ref type="bibr" target="#b46">(47)</ref>.</s><s>Studies by Burk et al <ref type="bibr" target="#b26">(27,</ref><ref type="bibr">48)</ref>, including a recent fascinating intervention study using different Se forms, suggests that as cirrhosis increases the liver is less able to adequately metabolize Se from selenomethionine sources.</s><s>Possibly, then, further Se deficiency caused by cirrhosis may predispose patients (especially those with already suboptimal Se status) to HCC.</s><s>This is an intriguing area of future investigation, and may partly explain the large effect sizes and differences in the results for Se and SePP observed in our study.</s><s>Thus, perhaps for subjects with pre-existing liver disease, a lower Se intake especially from sources with selenomethione will not adequately contribute to the functional Se availability.</s><s>These individuals are thus more likely to suffer Se deficiency which may further add to potential liver cancer progression.</s><s>This also may explain our observation that in subjects with clear liver damage scores the association of decreased HCC risk was significant for higher SePP levels only, i.e., this may reflect inadequate metabolism of selenomethionine to SePP, compounded for those also having lower baseline Se levels.</s><s>However, we have no data on these different sources of Se (such as use of supplements containing selenite) to adequately investigate these hypotheses.</s></p><p><s>Among the sex, lifestyle, dietary, and disease variables adjusted for in our analyses, mean Se levels differed by HBV and/or HCV infection and diabetes status while mean SePP levels differed by sex, diabetes, and fish and red meat intake (results not shown), in line with previous studies <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr">49)</ref>.</s><s>There were no statistically significant multiplicative interactions, except for the interaction between BMI and SePP for HCC.</s><s>Stratified analysis showed associations for SePP and HCC were stronger among overweight and obese participants (results not shown), possibly reflecting an influence of obesity on attenuating SePP expression and its regulation as a gluconeogenic enzyme <ref type="bibr" target="#b18">(19,</ref><ref type="bibr">50)</ref>.</s></p><p><s>The study strengths include measurement of the two most meaningful biomarkers of Se status, i.e., total Se and SePP serum concentrations <ref type="bibr" target="#b18">(19)</ref> in an appreciable sample size within a large, prospective study with extensive data on lifestyle and other dietary factors, liver function markers, and pre-diagnostic bloods.</s><s>The main limitations are the single time-point blood measure per subject and the relatively short follow-up time (~6 years).</s><s>However, exclusion of cases with less than two years of follow-up did not appreciably alter the findings.</s><s>There was limited power to assess the association of Se status with hepatobiliary cancer types with low study numbers, including IHBC, gallbladder, and cholangiocarcinoma cancers.</s><s>Another potential limitation applicable to all observational studies is the possibility of residual confounding.</s><s>However, in our models we adjusted for a large number of potentially relevant confounding variables.</s></p><p><s>In conclusion, the present study provides significant prospective data indicating a strong association between high Se status and a lower risk of HCC.</s><s>Randomised controlled trials in populations where Se status is suboptimal (e.g.</s><s>Western Europe) are needed to test whether increasing Se intake may reduce the risk of hepatobiliary cancers, especially for those at high risk (e.g.</s><s>HBV/HCV positive) for HCC and GBTC.</s><s>Table <ref type="table">1</ref> Selected baseline characteristics of incident liver cancer cases and their matched controls within the EPIC nested case-control study.</s><s>Am J Clin Nutr.</s><s>Author manuscript; available in PMC 2018 December 07.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2</head><p><s>ORs and 95% confidence intervals (95% CI) for hepatocellular carcinoma (HCC) and gallbladder and biliary tract cancers (GBTC) by circulating Se and SePP levels in the EPIC nested case-control study.</s><s>Additionally adjusted for body mass index (kg/m2, continuous), waist circumference (cm, continuous), baseline alcohol intake (g/d, continuous), physical activity (METs, continuous), smoking status (never, former, current, unknown), education (none/primary, technical/professional, secondary, university or higher), alcohol intake pattern (never drinkers, former drinkers, drinkers only at recruitment, always drinkers), self-reported diabetes, and total energy intake (kcal/d).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 3</head><p><s>ORs and 95% confidence intervals (95% CI) for intrahepatic bile duct (IHBC), gallbladder, cholangiocarcinoma cancers by circulating Se and SePP levels in the EPIC nested case-control study.</s><s>a ORs and 95% CI estimated by conditional logistic regression conditioned on the matching factors.</s></p><p><s>b Additionally adjusted for body mass index (kg/m2, continuous), waist circumference (cm, continuous), baseline alcohol intake (g/d, continuous), physical activity (METs, continuous), smoking status (never, former, current, unknown), education (none/primary, technical/professional, secondary, university or higher), alcohol intake pattern (never drinkers, former drinkers, drinkers only at recruitment, always drinkers), self-reported diabetes, and total energy intake (kcal/d).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>RF, Hill KE, Motley AK, Byrne DW, Norsworthy BK.</s><s>Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial.</s><s>Am J Clin Nutr.</s><s>2015; 102:1126-33.</s><s>[PubMed: 26468123] 49.</s><s>Bettinger D, Schultheiss M, Hennecke N, Panther E, Knüppel E, Blum HE, Thimme R, Spangenberg HC.</s><s>Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study.</s><s>Hepatol.</s><s>2013; 57:2543-4.</s><s>50.</s><s>Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, Klotz L-O, Steinbrenner H. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors.</s><s>Hepatol.</s><s>2008; 48:1998-2006.</s><s>Hughes et al.</s><s>Page 16</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Nutr.</s><s>Author manuscript; available in PMC 2018 December 07.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Prospective Investigation into Cancer and Nutrition; BMI, body mass index; SD, standard deviation; p-values from t-tests (continuous variables) or chi-square test (categorical variables).</s><s>Missing values were not excluded from percentage calculations, thus the sum of percents across sub-groups may not add up to 100%.</s><s>a Self-reported data.</s><s>b No information on past alcohol consumption was available for the following EPIC centers: Naples, Bilthoven, Umeå, Malmö, and Norway.</s><s>c Ranges from 0 to 6; the score was grouped in categories as 0, ≥1 abnormal liver function tests (ALT&gt;55 U/L, AST&gt;34 U/L, GGT men &gt;64 U/L, GGT women &gt; 36 U/L, AP &gt; 150 U/L, albumin &lt; 35 g/L, total bilirubin &gt; 20.5 μmol/L; based on the values provided by the laboratory).</s><s>d Available for 106 HCC, 96 GBTC, and 36 IHBC cases and their matched controls.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>21 )</head><label>21</label><figDesc><div><p><s>Abbreviations: EPIC, European Prospective Investigation into Cancer and Nutrition; CI, confidence interval; OR, incidence rate ratio; Se, selenium; SePP, selenoprotein P. a Gallbladder and biliary tract cancers (GBTC) included tumours in the gallbladder, extrahepatic bile ducts, ampulla of Vater, and biliary tract.</s><s>b ORs and 95% CI estimated by conditional logistic regression conditioned on the matching factors.c</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Hepatocellular carcinoma (HCC) Gallbladder &amp; biliary tract cancers (GBTC) a No. of ca/co Matching factors b OR (95% CI) Multivariable adjusted c OR (95% CI) No. of ca/co Matching factors b OR (95% CI) Multivariable adjusted c OR (95% CI) Se, µg/L</head><label></label><figDesc></figDesc><table><row><cell>Tertiles</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;80.5</cell><cell>60/37</cell><cell>ref.</cell><cell>ref.</cell><cell>47/34</cell><cell>ref.</cell><cell>ref.</cell></row><row><cell>80.6-94.4</cell><cell>34/30</cell><cell>0.62 (0.32, 1.21)</cell><cell>0.88 (0.35, 2.21)</cell><cell>32/33</cell><cell>0.69 (0.35, 1.36)</cell><cell>0.63 (0.29, 1.37)</cell></row><row><cell>&gt;94.5</cell><cell>12/39</cell><cell>0.16 (0.07, 0.40)</cell><cell>0.18 (0.05, 0.66)</cell><cell>17/29</cell><cell>0.38 (0.17, 0.87)</cell><cell>0.37 (0.13, 1.03)</cell></row><row><cell>p-trend</cell><cell></cell><cell>&lt;0.001</cell><cell>0.016</cell><cell></cell><cell>0.022</cell><cell>0.055</cell></row><row><cell>Per 20 µg/L</cell><cell>106/106</cell><cell>0.40 (0.27, 0.60)</cell><cell>0.41 (0.23, 0.72)</cell><cell>96/96</cell><cell>0.74 (0.51, 1.07)</cell><cell>0.74 (0.47, 1.18)</cell></row><row><cell>SePP, mg/L</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Tertiles</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;4.9</cell><cell>64/31</cell><cell>ref.</cell><cell>ref.</cell><cell>40/31</cell><cell>ref.</cell><cell>ref.</cell></row><row><cell>p-trend</cell><cell></cell><cell>&lt;0.0001</cell><cell>&lt;0.0001</cell><cell></cell><cell>0.033</cell><cell>0.016</cell></row></table><note><p><s>5-6.3 42/43 0.41 (0.21, 0.82) 0.43 (0.18, 0.99) 39/36 0.67 (0.31, 1.46) 0.46 (0.18, 1.17) &gt;6.4 15/47 0.11 (0.04, 0.28) 0.09 (0.03, 0.32) 21/33 0.39 (0.16, 0.94) 0.27 (0.09, 0.78) Per 1.5 mg/L 121/121 0.40 (0.27, 0.59) 0.37 (0.21, 0.63) 100/100 0.87 (0.60, 1.26) 0.79 (0.51, 1.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Am J Clin Nutr. Author manuscript; available in PMC 2018 December 07.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Carola Geiler and Torsten Schulz for help with the SePP status analyses in the lab of LS.</s><s>The authors have declared that no competing interests exist.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AFP</head><p><s>α-fetoprotein</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Soerjomataram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ervik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dikshit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rebelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Parkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><surname>Globocan</surname></persName>
		</author>
		<idno>v1.0</idno>
		<ptr target="http://globocan.iarc.fr" />
		<imprint>
			<date type="published" when="2012">2012. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Global cancer statistics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Center</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="69" to="90" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21296855</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis</title>
		<author>
			<persName><forename type="first">A-I</forename><surname>Gomaa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">4300</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18666317</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Altekruse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Mcglynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Reichman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1485" to="1491" />
			<date type="published" when="2005">2005. 2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19224838</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">International trends in liver cancer incidence rates</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Center</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomark Prev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2362" to="2368" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Current surgical treatment for bile duct cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Seyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Makuuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1505" to="1515" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17461441</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Epidemiology and risk factors of biliary tract and primary liver tumors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Augustine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Surg Oncol Clin N Am</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">24560105</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Selenium and cancer: a story that should not be forgotten-insights from genomics</title>
		<author>
			<persName><forename type="first">C</forename><surname>Méplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hesketh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Treat Res</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="145" to="166" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24114479</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Selenoproteins: molecular pathways and physiological roles</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Labunskyy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hatfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Gladyshev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="739" to="777" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24987004</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Selenium in human health and disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Fairweather-Tait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Broadley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Collings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hesketh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hurst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid Redox Signal</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1337" to="1383" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 20812787</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Selenoproteins and human health: insights from epidemiological data</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Rayman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1790</biblScope>
			<biblScope unit="page" from="1533" to="1540" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19327385</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Regulation and function of selenoproteins in human disease</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Bellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Raman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Reeves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Berry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">422</biblScope>
			<biblScope unit="page" from="11" to="22" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19627257</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Méplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rohrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Steinbrecher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Linseisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hesketh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e48709</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23133653</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Toward understanding success and failures in the use of selenium for cancer prevention</title>
		<author>
			<persName><forename type="first">H</forename><surname>Steinbrenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Speckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid Redox Signal</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="181" to="191" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23421468</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fedirko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jenab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Méplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Freisling</surname></persName>
		</author>
		<author>
			<persName><surname>Bueno-De-Mesquita Hb As</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hybsier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Czuban</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="1149" to="1161" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25042282</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Regulation of Selenium Metabolism and Transport</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Nutr</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">150514143029003</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Methods of assessment of selenium status in humans: a systematic review</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ashton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Harvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casgrain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Fairweather-Tait</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="2025S" to="2039S" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19420095</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Armah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Dainty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Teucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Goldson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Broadley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Motley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fairweather-Tait</forename><surname>Sj</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="923" to="931" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20181815</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Biomarkers of Selenium Status</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Combs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="2209" to="2236" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25835046</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Status of Essential Trace Minerals and Oxidative Stress in Viral Hepatitis C Patients with Nonalcoholic Fatty Liver Disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Med Sci</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="730" to="737" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23630437</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Kasaikina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Turanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Avanesov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schweizer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seeher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Bronson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Novoselov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hatfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Gladyshev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1089" to="1095" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23389288</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Trace Elem Med Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="255" to="261" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22425635</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Einwaechter H. Selenium and Selenoprotein Deficiencies Induce Widespread Pyogranuloma Formation in Mice, while High Levels of Dietary Selenium Decrease Liver Tumor Size Driven by TGFα</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Moustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Anver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Perella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Combs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e57389</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23460847</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rohr-Udilova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sieghart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Eferl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stoiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Björkhem-Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stolze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sagmeister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1112" to="1121" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A possible predictive marker of progression for hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Di Stasio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Colonna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nazzaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Polimeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Scala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Castello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Costantini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1247" to="1251" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22848296</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Sakoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Graubard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>London</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W-Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F-M</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Mcglynn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="618" to="624" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15704105</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Plasma selenium in patients with cirrhosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Early</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Boeglin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="794" to="798" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Study of Trace Elements in Liver Cirrhosis Patients and Their Role in Prognosis of Disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Nangliya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nijhawan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mishra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Trace Elem Res</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="30" to="40" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25613583</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Trace metals in liver disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mcclain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marsano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bacon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Liver Dis</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="321" to="339" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note>PubMed: 1763338</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hesketh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Nutr</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="157" to="177" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18494599</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Horng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Liaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="367" to="374" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed: 10453813</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection</title>
		<author>
			<persName><forename type="first">E</forename><surname>Riboli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Slimani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Norat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fahey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Charrondière</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hémon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Casagrande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vignat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Public Health Nutr</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1113" to="1124" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12639222</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">European Prospective Investigation into Cancer and Nutrition</title>
		<author>
			<persName><forename type="first">E</forename><surname>Riboli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kaaks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S6" to="14" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>The EPIC Project: rationale and study design. Suppl. PubMed: 9126529</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Trichopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bamia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lagiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fedirko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trepo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jenab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pischon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Nöthlings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Overved</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tjønneland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1686" to="1695" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22021666</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans</title>
		<author>
			<persName><forename type="first">V</forename><surname>Fedirko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lukanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bamia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trichopolou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trepo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Nöthlings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schlesinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Aleksandrova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boffetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tjønneland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="543" to="553" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23123507</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The choice of biomarkers determines the selenium status in young German vegans and vegetarians</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hoeflich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hollenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Behrends</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hoeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stosnach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1601" to="1604" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20637135</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Differential responses to selenomethionine supplementation by sex and genotype in healthy adults</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Combs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Idso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hoeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hoefig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Chiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="1514" to="1525" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 21936966</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Motley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Byrne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Burk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="525" to="531" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20573787</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Hepatic metabolite profiles in mice with a suboptimal selenium status</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Geillinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rathmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fiamoncini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Daniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Kipp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Biochem</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="914" to="922" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24917045</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Motley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Winfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Capecchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Burk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page">23038251</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Role of selenium and glutathione peroxidase on development, growth, and oxidative balance in rat offspring</title>
		<author>
			<persName><forename type="first">F</forename><surname>Nogales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ojeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fenutría</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Murillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Carreras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Reprod Camb Engl</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="659" to="667" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Renko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Renner-Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yeung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hollenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scharpf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schweizer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">409</biblScope>
			<biblScope unit="page" from="741" to="749" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17961124</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stoedter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Renko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hög</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">429</biblScope>
			<biblScope unit="page" from="43" to="51" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20370716</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Hypoxia reduces and redirects selenoprotein biosynthesis</title>
		<author>
			<persName><forename type="first">N-P</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Martitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Renko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stoedter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hybsier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Met Integr Biometal Sci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1079" to="1086" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hoefig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Renko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Birringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schomburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Biochem</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="945" to="955" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21190829</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Effects of nationwide addition of selenium to fertilizers on foods, and animal and human health in Finland: From deficiency to optimal selenium status of the population</title>
		<author>
			<persName><forename type="first">G</forename><surname>Alfthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eurola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ekholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Venäläinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Root</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Korkalainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hartikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Salminen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hietaniemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Aspila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Trace Elem Med Biol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="142" to="147" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 24908353</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Trace Elem Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="117" to="124" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>PubMed: 9152515</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
